Published in Mol Pharmacol on April 19, 2011
The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels. Br J Pharmacol (2013) 1.88
Applying linear and non-linear methods for parallel prediction of volume of distribution and fraction of unbound drug. PLoS One (2013) 1.43
Cysteine modification reveals which subunits form the ligand binding site in human heteromeric 5-HT3AB receptors. J Physiol (2011) 1.29
VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors. J Pharmacol Exp Ther (2012) 0.95
The pharmacological profile of ELIC, a prokaryotic GABA-gated receptor. Neuropharmacology (2012) 0.93
Azemiopsin from Azemiops feae viper venom, a novel polypeptide ligand of nicotinic acetylcholine receptor. J Biol Chem (2012) 0.93
Cys-loop receptor channel blockers also block GLIC. Biophys J (2011) 0.90
Discriminating between 5-HT₃A and 5-HT₃AB receptors. Br J Pharmacol (2013) 0.87
Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation. J Neuroinflammation (2014) 0.86
A golden approach to ion channel inhibition. Trends Pharmacol Sci (2013) 0.81
A single amino acid determines the toxicity of Ginkgo biloba extracts. FASEB J (2012) 0.79
A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors. Br J Pharmacol (2013) 0.78
Structure-activity relationships of quinoxaline-based 5-HT3A and 5-HT3AB receptor-selective ligands. ChemMedChem (2013) 0.78
Phenylalanine in the pore of the Erwinia ligand-gated ion channel modulates picrotoxinin potency but not receptor function. Biochemistry (2014) 0.76
Identification of Glycyrrhiza as the rikkunshito constituent with the highest antagonistic potential on heterologously expressed 5-HT3A receptors due to the action of flavonoids. Front Pharmacol (2015) 0.76
Mixed antagonistic effects of the ginkgolides at recombinant human ρ1 GABAC receptors. Neuropharmacology (2012) 0.75
5-HT3 Receptor Brain-Type B-Subunits are Differentially Expressed in Heterologous Systems. ACS Chem Neurosci (2015) 0.75
An atypical residue in the pore of Varroa destructor GABA-activated RDL receptors affects picrotoxin block and thymol modulation. Insect Biochem Mol Biol (2014) 0.75
Noncompetitive Inhibition of 5-HT3 Receptors by Citral, Linalool, and Eucalyptol Revealed by Nonlinear Mixed-Effects Modeling. J Pharmacol Exp Ther (2015) 0.75
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs. Neuron (1992) 10.25
Structure and gating mechanism of the acetylcholine receptor pore. Nature (2003) 8.30
Rings of negatively charged amino acids determine the acetylcholine receptor channel conductance. Nature (1988) 6.35
A point mutation in a Drosophila GABA receptor confers insecticide resistance. Nature (1993) 2.75
The atypical M2 segment of the beta subunit confers picrotoxinin resistance to inhibitory glycine receptor channels. EMBO J (1992) 2.38
Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors. J Virol Methods (2006) 2.36
Treatment of irritable bowel syndrome. Am Fam Physician (2005) 2.09
GABA receptor mechanisms in the central nervous system. Prog Neurobiol (1991) 1.68
Further concerns over Cheng-Prusoff analysis. Trends Pharmacol Sci (1993) 1.67
Interaction of picrotoxin with GABAA receptor channel-lining residues probed in cysteine mutants. Biophys J (1995) 1.56
Atomic force microscopy reveals the stoichiometry and subunit arrangement of 5-HT3 receptors. Proc Natl Acad Sci U S A (2005) 1.52
Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding. J Biol Chem (2005) 1.44
Point mutations in the M2 region of the alpha, beta, or gamma subunit of the GABAA channel that abolish block by picrotoxin. Receptors Channels (1995) 1.36
Cloning of a gamma-aminobutyric acid type C receptor subunit in rat retina with a methionine residue critical for picrotoxinin channel block. Proc Natl Acad Sci U S A (1995) 1.31
Molecular determinants of ginkgolide binding in the glycine receptor pore. J Neurochem (2006) 1.28
Mutations affecting the glycine receptor agonist transduction mechanism convert the competitive antagonist, picrotoxin, into an allosteric potentiator. J Biol Chem (1995) 1.27
Evidence for a centrally located gate in the pore of a serotonin-gated ion channel. J Neurosci (2002) 1.26
Structural and electrostatic properties of the 5-HT3 receptor pore revealed by substituted cysteine accessibility mutagenesis. J Biol Chem (2001) 1.24
The location of a closed channel gate in the GABAA receptor channel. J Gen Physiol (2007) 1.18
Pharmacological comparison of human homomeric 5-HT3A receptors versus heteromeric 5-HT3A/3B receptors. Neuropharmacology (2001) 1.17
Ginkgolides and bilobalide: their physical, chromatographic and spectroscopic properties. Bioorg Med Chem (2005) 1.15
A single amino acid in gamma-aminobutyric acid rho 1 receptors affects competitive and noncompetitive components of picrotoxin inhibition. Proc Natl Acad Sci U S A (1995) 1.14
Picrotoxin blockade of invertebrate glutamate-gated chloride channels: subunit dependence and evidence for binding within the pore. J Neurochem (1999) 1.12
Molecular determinants of picrotoxin inhibition of 5-hydroxytryptamine type 3 receptors. J Pharmacol Exp Ther (2005) 1.09
Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor. Biophys J (2010) 1.08
The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5-HT3 receptors. Br J Pharmacol (2007) 1.07
Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor. Biophys J (2003) 1.06
A proposed structural basis for picrotoxinin and picrotin binding in the glycine receptor pore. J Neurochem (2007) 1.04
Stoichiometry of a pore mutation that abolishes picrotoxin-mediated antagonism of the GABAA receptor. J Physiol (2006) 1.03
A single beta subunit M2 domain residue controls the picrotoxin sensitivity of alphabeta heteromeric glycine receptor chloride channels. J Neurochem (2001) 1.01
Two novel residues in M2 of the gamma-aminobutyric acid type A receptor affecting gating by GABA and picrotoxin affinity. J Biol Chem (2000) 1.00
Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels. Mol Pharmacol (1996) 0.98
Structure-activity analysis of ginkgolide binding in the glycine receptor pore. J Neurochem (2008) 0.97
The 5-HT3B subunit confers reduced sensitivity to picrotoxin when co-expressed with the 5-HT3A receptor. Brain Res Mol Brain Res (2003) 0.96
Terpene trilactones from Ginkgo biloba are antagonists of cortical glycine and GABA(A) receptors. J Biol Chem (2003) 0.95
Stoichiometric pore mutations of the GABAAR reveal a pattern of hydrogen bonding with picrotoxin. Biophys J (2008) 0.95
Identification of a novel residue within the second transmembrane domain that confers use-facilitated block by picrotoxin in glycine alpha 1 receptors. J Biol Chem (2001) 0.92
Inhibition of type A GABA receptors by L-type calcium channel blockers. Neuroscience (2004) 0.91
Diltiazem causes open channel block of recombinant 5-HT3 receptors. J Physiol (1999) 0.90
A picrotoxin-specific conformational change in the glycine receptor M2-M3 loop. J Biol Chem (2005) 0.89
Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant alpha1beta2gamma2L GABAA receptors. Eur J Pharmacol (2004) 0.87
Stoichiometric analysis of the TM2 6' phenylalanine mutation on desensitization in alpha1beta2 and alpha1beta2gamma2 GABA A receptors. Neurosci Lett (2007) 0.87
Ginkgolide B and bilobalide block the pore of the 5-HT₃receptor at a location that overlaps the picrotoxin binding site. Neuropharmacology (2010) 0.86
Mechanisms for picrotoxinin and picrotin blocks of alpha2 homomeric glycine receptors. J Biol Chem (2007) 0.85
NOESY on neurotoxins: NMR and conformational assignments of picrotoxins. Phytochem Anal (2001) 0.84
The beta subunit increases the ginkgolide B sensitivity of inhibitory glycine receptors. Neuropharmacology (2005) 0.83
Effects of diltiazem on human nicotinic acetylcholine and GABA(A) receptors. Neuropharmacology (2000) 0.82
Mixed antagonistic effects of bilobalide at rho1 GABAC receptor. Neuroscience (2005) 0.80
A role for the Val291 residue within the transmembrane domain 2 in diltiazem- and TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester]-mediated 5-hydroxytryptamine type 3A receptor regulations. Biol Pharm Bull (2009) 0.77
Modulation of glycine responses by dihydropyridines and verapamil in rat spinal neurons. Eur J Neurosci (2001) 0.77
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
5-HT3 receptors. Curr Pharm Des (2006) 1.49
Cysteine modification reveals which subunits form the ligand binding site in human heteromeric 5-HT3AB receptors. J Physiol (2011) 1.29
Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor. Biophys J (2010) 1.08
The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5-HT3 receptors. Br J Pharmacol (2007) 1.07
Antimalarial drugs inhibit human 5-HT(3) and GABA(A) but not GABA(C) receptors. Br J Pharmacol (2008) 1.06
Loop B is a major structural component of the 5-HT3 receptor. Biophys J (2008) 0.96
VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors. J Pharmacol Exp Ther (2012) 0.95
The evidence for clinical efficacy of rose hip and seed: a systematic review. Phytother Res (2006) 0.88
Discriminating between 5-HT₃A and 5-HT₃AB receptors. Br J Pharmacol (2013) 0.87
The effects of cyclopentane and cyclopentene analogues of GABA at recombinant GABA(C) receptors. Eur J Pharmacol (2001) 0.81
Mixed antagonistic effects of bilobalide at rho1 GABAC receptor. Neuroscience (2005) 0.80
A single channel mutation alters agonist efficacy at 5-HT3A and 5-HT3AB receptors. Br J Pharmacol (2013) 0.78
Effectiveness of Petasites hybridus preparations in the prophylaxis of migraine: a systematic review. Phytomedicine (2006) 0.76
Unbinding pathways of an agonist and an antagonist from the 5-HT3 receptor. Biophys J (2005) 0.76
R-(-)-beta-phenyl-GABA is a full agonist at GABAB receptors in brain slices but a partial agonist in the ileum. Eur J Pharmacol (1993) 0.75
ZAPA, a substrate for the neuronal high affinity GABA uptake system in rat brain slices. Neurochem Int (1991) 0.75